Associations between microRNA (miR-21, 126, 155 and 221), albuminuria and heavy metals in Hong Kong Chinese adolescents

Clinica Chimica Acta

Volumn 413, Issue 13-14, 2012, Pages 1053-1057

  Kong, Alice P S ^a   Xiao, Kang ^a   Choi, Kai Chow ^a   Wang, Gang ^a   Chan, Michael H M ^a   Ho, Chung Shun ^a   Chan, Iris ^a   Wong, Chun Kwok ^a   Chan, Juliana C N ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adolescents; Albuminuria; Arsenic; Cadmium; Lead; Mercury

Indexed keywords

ARSENIC; CADMIUM; HEAVY METAL; LEAD; MERCURY; MICRORNA 126; MICRORNA 155; MICRORNA 21; MICRORNA 221;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HONG KONG; HUMAN; MICROALBUMINURIA; POPULATION RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; URINE LEVEL;

EID: 84860368815     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.02.014     Document Type: Article

References (26)

1. Huang M., Choi S.J., Kim D.W., et al. Risk assessment of low-level cadmium and arsenic on the kidney. J Toxicol Environ Health A 2009, 72(21-22):1493-1498.
2. Houston M.C. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med 2007, 13(2):S128-S133.
3. Hong F., Jin T., Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals 2004, 17(5):573-580.
4. Navas-Acien A., Silbergeld E.K., Sharrett R., Calderon-Aranda E., Selvin E., Guallar E. Metals in urine and peripheral arterial disease. Environ Health Perspect 2005, 113(2):164-169.
5. Harfe B.D. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005, 15(4):410-415.
6. Krichevsky A.M., Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009, 13(1):39-53.
7. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009, 104(4):476-487. Epub 2009 Jan 15.
8. Fish J.E., Santoro M.M., Morton S.U., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15(2):272-284.
9. Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006, 281(27):18277-18284. Epub 2006 May 4.
10. Ozaki R., Qiao Q., Wong G.W., et al. Overweight, family history of diabetes and attending schools of lower academic grading are independent predictors for metabolic syndrome in Hong Kong Chinese adolescents. Arch Dis Child 2007, 92((3):224-228. Epub 2006 Nov 6.
11. Kong A.P., Choi K.C., Cockram C.S., et al. Independent associations of alanine aminotransferase (ALT) levels with cardiovascular risk factor clustering in Chinese adolescents. J Hepatol 2008, 49(1):115-122. Epub 2008 Mar 26.
12. Mogensen C.E., Vestbo E., Poulsen P.L., et al. Microalbuminuria and potential confounders. Diabetes Care 1995, 18:572-581.
13. Chan H.M., Chan I.H., Kong A.P., et al. Cold-vapour atomic absorption spectrometry underestimates total mercury in blood and urine compared to inductively-coupled plasma mass spectrometry: an important factor for determining mercury reference intervals. Pathology 2009, 41(5):467-472.
14. Saal S., Harvey S.J. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 2009, 18(4):317-323.
15. Zhang Z., Peng H., Chen J., et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 2009, 583(12):2009-2014. Epub 2009 May 19.
16. Kato M., Putta S., Wang M., et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009, 11(7):881-889. Epub 2009 Jun 21.
17. Wang Q., Wang Y., Minto A.W., et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008, 22(12):4126-4135. Epub 2008 Aug 20.
18. Li Z., Piao F., Liu S., Qu Y., Wang S. Subchronic exposure to arsenic trioxide-induced oxidative DNA damage in kidney tissue of mice. Exp Toxicol Pathol 2009, 62(5):543-547. Epub 2009 Aug 14.
19. Hsueh Y.M., Chung C.J., Shiue H.S., et al. Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am J Kidney Dis 2009, 54(5):859-870. Epub 2009 Aug 14.
20. Langworth S., Elinder C.G., Sundquist K.G., Vesterberg O. Renal and immunological effects of occupational exposure to inorganic mercury. Br J Ind Med 1992, 49(6):394-401.
21. Franchini I., Alinovi R., Bergamaschi E., Mutti A. Contribution of studies on renal effects of heavy metals and selected organic compounds to our understanding of the progression of chronic nephropathies towards renal failure. Acta Biomed 2005, 76(Suppl. 2):58-67.
22. Barregard L., Trachtenberg F., McKinlay S. Renal effects of dental amalgam in children: the New England children's amalgam trial. Environ Health Perspect 2008, 116(3):394-399.
23. Navas-Acien A., Tellez-Plaza M., Guallar E., et al. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 2009, 170(9):1156-1164. Epub 2009 Aug 21.
24. Haswell-Elkins M., Satarug S., O'Rourke P., et al. Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes. Environ Res 2008, 106(3):379-383. Epub 2007 Nov 28.
25. Jin T., Kong Q., Ye T., Wu X., Nordberg G.F. Renal dysfunction of cadmium-exposed workers residing in a cadmium-polluted environment. Biometals 2004, 17(5):513-518.
26. Noonan C.W., Sarasua S.M., Campagna D., Kathman S.J., Lybarger J.A., Mueller P.W. Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ Health Perspect 2002, 110(2):151-155.